Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Paid-in Capital in Excess of Par Value	Retained Deficit	Retained Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2019	$ 886,772	$ (1,525)	$ 2,124	$ 966,762	$ (73,333)	$ (1,525)	$ (8,781)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	25,826		27	25,799
Shares repurchased and retired related to stock-based compensation	(2,573)		(7)	(2,566)
Other Comprehensive Income (Loss)	(4,329)						(4,329)
Net income (loss)	(346,883)				(346,883)
Ending balance at Dec. 31, 2020	557,288		2,144	989,995	(421,741)		(13,110)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	24,677		19	24,658
Shares repurchased and retired related to stock-based compensation	(2,699)		(3)	(2,696)
Equity issued in connection with acquisition	82,323		260	82,063
Other Comprehensive Income (Loss)	4,851						4,851
Net income (loss)	(119,423)				(119,423)
Ending balance at Dec. 31, 2021	547,017		2,420	1,094,020	(541,164)		(8,259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	29,595		39	29,556
Shares repurchased and retired related to stock-based compensation	(7,500)		(9)	(7,491)
Equity issued in connection with acquisition	4,207		5	4,202
Shares repurchased and retired related to stock repurchase program	(112,910)		(115)	(112,795)
Other Comprehensive Income (Loss)	14,541						14,541
Net income (loss)	314,969				314,969		1,356
Ending balance at Dec. 31, 2022	$ 789,919		$ 2,340	$ 1,007,492	$ (226,195)		$ 6,282